The emerging role of glycolysis and immune evasion in gastric cancer
Abstract Gastric cancer (GC) is the fifth most common malignancy and the third leading cause of cancer-related deaths worldwide. Similar to other types of tumors, GC cells undergo metabolic reprogramming and switch to a “predominantly glycolytic” metabolic pattern to promote its survival and metasta...
Main Authors: | Shanshan Zheng, Huaizhi Li, Yaqi Li, Xu Chen, Junyu Shen, Menglin Chen, Cancan Zhang, Jian Wu, Qingmin Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-12-01
|
Series: | Cancer Cell International |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12935-023-03169-1 |
Similar Items
-
PLXDC1 Can Be a Biomarker for Poor Prognosis and Immune Evasion in Gastric Cancer
by: Li X, et al.
Published: (2022-09-01) -
Tumor microenvironment-mediated immune evasion in hepatocellular carcinoma
by: Chen Chen, et al.
Published: (2023-02-01) -
Metformin suppresses proliferation and glycolysis of gastric cancer by modulating ADAMTS12
by: Rui Chen, et al.
Published: (2024-01-01) -
Immune evasion in esophageal squamous cell cancer: From the perspective of tumor microenvironment
by: Rongyang Li, et al.
Published: (2023-01-01) -
PLA2G4A and ACHE modulate lipid profiles via glycerophospholipid metabolism in platinum-resistant gastric cancer
by: Menglin Chen, et al.
Published: (2024-03-01)